Notably, this mixture synergistically decreases the xanthine oxidoreductase (XOR) activity, inhibiting UA (uric acid) and ROS (reactive oxygen species) formation, and therefore it may contribute to the treatment of the dry eye syndrome, reducing irritation and related pathological conditions. The gene discussed is XDH; the disease is dry eye syndrome.